Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin Resistance Changes After Midazolam
NCT03791424Phase 4Completed
- Sponsor
- Charles University
- Start
- Oct 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind, single-arm trial of midazolam in anxiety disorder, sponsored by Charles University. Primary endpoint: Changes of skin resistance during sedation. Started Oct 2014; status: completed.
02
Drugs
midazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03791424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791424.